arrow
R

Rob van der Kant

VIB
H指数:16
被引数:1,130

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Directed disruption of IL2 aggregation and receptor binding sites produces designer biologics with enhanced specificity and improved production capacity

定向破坏IL2的聚集和受体结合位点,产生具有增强特异性和改进生产能力的设计生物制剂。

2025-01-011
OAAI
Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature

B.1.214.2 SARS-CoV-2谱系的出现,具有类似Omicron的尖峰插入和独特的上呼吸道免疫特征

2024-10-101
OAAI
Reverse engineering synthetic antiviral amyloids (vol 11, 2832, 2020)
2023-06-130
OAAI
Reduced Levels of Misfolded and Aggregated Mutant p53 by Proteostatic Activation
CELLS
IF5.2
2023-03-210
OAAI
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein
2023-02-224
OAAI
Defective Sec61α1 underlies a novel cause of autosomal dominant severe congenital neutropenia
2020-11-0130
OAAI
Reverse engineering synthetic antiviral amyloids
2020-06-0530
OAAI